Recall: Quinapril
Jan. 2023Pharmacy Updates
Lupin Pharmaceuticals Inc. has recalled four lots of Quinapril Tablets because they contain of a nitrosamine impurity, N-Nitroso-Quinapril, observed in recent testing above the Acceptable Daily Intake (ADI) level. Such impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time. Read the full text of the Quinapril recall.
Recent Announcements
CME Webinar: Getting it Right from the Start: Identifying Patient Advanced Care Directives
Please join us for a live, CME-accredited webinar on Thursday, Oct. 15, 2026 that will educate providers on identifying advanced directives and surrogate decision makers on admission.Oct. 2026Education/Webinars
CME Webinar: Navigating Grief Conversations
Please join us for a live, CME-accredited webinar on Thursday, Nov. 12, 2026, that will enhance your confidence and effectiveness in supporting patients dealing with loss & grief.Oct. 2026Education/Webinars
Provider OnLine Login Changes for UPMC Employees and UPMC Children’s Hospital of Pittsburgh Employees
UPMC employees and UPMC Children’s Hospital of Pittsburgh employees will now use their email address to access Provider OnLine.Oct. 2026Important Notices